JP2018502893A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018502893A5 JP2018502893A5 JP2017539029A JP2017539029A JP2018502893A5 JP 2018502893 A5 JP2018502893 A5 JP 2018502893A5 JP 2017539029 A JP2017539029 A JP 2017539029A JP 2017539029 A JP2017539029 A JP 2017539029A JP 2018502893 A5 JP2018502893 A5 JP 2018502893A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- chlorophyllin
- compositions
- disease treatment
- treating kidney
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 29
- 229940099898 chlorophyllin Drugs 0.000 claims 12
- 235000019805 chlorophyllin Nutrition 0.000 claims 12
- 208000017169 kidney disease Diseases 0.000 claims 11
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 4
- 229910052802 copper Inorganic materials 0.000 claims 4
- 239000010949 copper Substances 0.000 claims 4
- JVOGSHDZLOJKKR-MXFMKSRJSA-I [Na+].[Na+].[Na+].[Mg++].CCc1c(C)c2cc3[n-]c(c(C)c3C=C)c(C)c3nc(C[C@H]3CCC([O-])=O)c(CC([O-])=O)c3[n-]c(cc1n2)c(C)c3C([O-])=O Chemical compound [Na+].[Na+].[Na+].[Mg++].CCc1c(C)c2cc3[n-]c(c(C)c3C=C)c(C)c3nc(C[C@H]3CCC([O-])=O)c(CC([O-])=O)c3[n-]c(cc1n2)c(C)c3C([O-])=O JVOGSHDZLOJKKR-MXFMKSRJSA-I 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 239000004615 ingredient Substances 0.000 claims 2
- 230000003907 kidney function Effects 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 229910052700 potassium Inorganic materials 0.000 claims 2
- 239000011591 potassium Substances 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 102000001554 Hemoglobins Human genes 0.000 claims 1
- 108010054147 Hemoglobins Proteins 0.000 claims 1
- 108010009736 Protein Hydrolysates Proteins 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 238000011260 co-administration Methods 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- HWDGVJUIHRPKFR-UHFFFAOYSA-I copper;trisodium;18-(2-carboxylatoethyl)-20-(carboxylatomethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18-dihydroporphyrin-21,23-diide-2-carboxylate Chemical compound [Na+].[Na+].[Na+].[Cu+2].N1=C(C(CC([O-])=O)=C2C(C(C)C(C=C3C(=C(C=C)C(=C4)[N-]3)C)=N2)CCC([O-])=O)C(=C([O-])[O-])C(C)=C1C=C1C(CC)=C(C)C4=N1 HWDGVJUIHRPKFR-UHFFFAOYSA-I 0.000 claims 1
- 229940109239 creatinine Drugs 0.000 claims 1
- 230000007423 decrease Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 239000007903 gelatin capsule Substances 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 229910052742 iron Inorganic materials 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 239000003531 protein hydrolysate Substances 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 229940079841 sodium copper chlorophyllin Drugs 0.000 claims 1
- 235000013758 sodium copper chlorophyllin Nutrition 0.000 claims 1
- 239000007916 tablet composition Substances 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN178MU2015 | 2015-01-19 | ||
| IN178/MUM/2015 | 2015-01-19 | ||
| PCT/IN2016/050017 WO2016116950A2 (en) | 2015-01-19 | 2016-01-15 | Chlorophyll composition |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020166136A Division JP2021006555A (ja) | 2015-01-19 | 2020-09-30 | クロロフィル組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018502893A JP2018502893A (ja) | 2018-02-01 |
| JP2018502893A5 true JP2018502893A5 (enExample) | 2018-04-12 |
| JP6772151B2 JP6772151B2 (ja) | 2020-10-21 |
Family
ID=56417899
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017539029A Active JP6772151B2 (ja) | 2015-01-19 | 2016-01-15 | クロロフィル組成物 |
| JP2020166136A Pending JP2021006555A (ja) | 2015-01-19 | 2020-09-30 | クロロフィル組成物 |
| JP2025010109A Pending JP2025066799A (ja) | 2015-01-19 | 2025-01-23 | クロロフィル組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020166136A Pending JP2021006555A (ja) | 2015-01-19 | 2020-09-30 | クロロフィル組成物 |
| JP2025010109A Pending JP2025066799A (ja) | 2015-01-19 | 2025-01-23 | クロロフィル組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12194052B2 (enExample) |
| EP (1) | EP3247323B1 (enExample) |
| JP (3) | JP6772151B2 (enExample) |
| CN (2) | CN107427417A (enExample) |
| AU (1) | AU2016210540B2 (enExample) |
| BR (1) | BR112017015338A2 (enExample) |
| EA (1) | EA201791319A1 (enExample) |
| ES (1) | ES2879996T3 (enExample) |
| SG (1) | SG11201705694VA (enExample) |
| WO (1) | WO2016116950A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2879996T3 (es) * | 2015-01-19 | 2021-11-23 | Chitra Vasant Savangikar | Composición de clorofila |
| EP4059493A1 (en) * | 2021-03-16 | 2022-09-21 | The Secretary, Department Of Atomic Energy | A chlorophyllin containing pharmaceutical composition for prevention of pathogenesis of coronavirus disease |
| WO2025203055A1 (en) * | 2024-03-26 | 2025-10-02 | Council Of Scientific And Industrial Research | Encapsulated dihydrofolate formulation for dietary supplementation as effective nutraceutical supplement and method of preparation thereof |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2729586A (en) | 1952-02-01 | 1956-01-03 | Rystan Company | Therapeutic compositions comprising water - soluble chlorophyll and salts of fatty acids |
| BE516996A (enExample) | 1952-02-19 | |||
| JPS55161863A (en) * | 1979-06-06 | 1980-12-16 | Paaku Deebisu Kk | Colored gelatin capsule |
| DE4033530A1 (de) * | 1990-10-22 | 1992-04-23 | Univ Schiller Jena | Kristallisationsinhibitor |
| JPH04327534A (ja) * | 1991-04-24 | 1992-11-17 | Mitsuo Namiki | 活性酸素による障害の予防及び治療剤 |
| JPH04356420A (ja) * | 1991-05-31 | 1992-12-10 | Nisshin Flour Milling Co Ltd | チアミン・コバルト・クロロフィリン錯化合物含有組成物 |
| JP3734360B2 (ja) * | 1998-03-18 | 2006-01-11 | エーザイ株式会社 | 銅クロロフィリンの塩を含有してなる製剤 |
| CN1078468C (zh) | 1998-07-02 | 2002-01-30 | 许德余 | 叶绿素铜钠盐用于制造抗胃粘膜损伤的组合物的用途 |
| JP3657203B2 (ja) | 2000-04-21 | 2005-06-08 | エーザイ株式会社 | 銅クロロフィリン塩含有液剤組成物 |
| JP2003081741A (ja) * | 2001-09-13 | 2003-03-19 | Nikko Seiyaku Kk | 皮膚外用剤 |
| JP4068442B2 (ja) * | 2001-12-03 | 2008-03-26 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 味覚改善組成物 |
| EP1846106B1 (en) * | 2005-01-31 | 2012-10-24 | Dong Wha Pharm. Co., Ltd. | Pharmaceutical composition for treating nephropathy and healthy food comprising herb extracts |
| WO2007143002A2 (en) * | 2006-05-31 | 2007-12-13 | Interhealth Nutraceuticals, Inc. | Nutraceutical treatments for diabetic and non-diabetic wound healing |
| US7947827B2 (en) * | 2006-06-30 | 2011-05-24 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Pharmaceutical formulation comprising a metaloporphyrin and method for its purification and use |
| CA2691691C (en) | 2007-06-20 | 2013-09-24 | Seth J. Baum | Compositions and methods of treating chronic kidney disease |
| JP2009256228A (ja) * | 2008-04-15 | 2009-11-05 | Lion Corp | 液体口腔用組成物 |
| CN102462671A (zh) | 2010-11-18 | 2012-05-23 | 何国增 | 叶绿素铜钠胶囊的制备方法 |
| CN102138919A (zh) * | 2011-01-28 | 2011-08-03 | 武汉联合药业有限责任公司 | 铁叶绿酸钠用于促进红细胞生成的新用途 |
| CN103027873A (zh) * | 2011-10-10 | 2013-04-10 | 马美琳 | 一种消炎止血牙膏 |
| CN103285097B (zh) | 2012-02-22 | 2014-12-10 | 西安世纪盛康药业有限公司 | 肾康注射液在制备防治放疗或化疗所致肾毒性药物中的应用 |
| AU2014205553A1 (en) * | 2013-01-08 | 2015-07-09 | Volant Holdings Gmbh | Activation of the endogenous ileal brake hormone pathway for organ regeneration and related compositions, methods of treatment, diagnostics, and regulatory systems |
| ES2879996T3 (es) * | 2015-01-19 | 2021-11-23 | Chitra Vasant Savangikar | Composición de clorofila |
-
2016
- 2016-01-15 ES ES16739893T patent/ES2879996T3/es active Active
- 2016-01-15 BR BR112017015338A patent/BR112017015338A2/pt not_active Application Discontinuation
- 2016-01-15 US US15/543,966 patent/US12194052B2/en active Active
- 2016-01-15 EP EP16739893.2A patent/EP3247323B1/en active Active
- 2016-01-15 SG SG11201705694VA patent/SG11201705694VA/en unknown
- 2016-01-15 CN CN201680006322.4A patent/CN107427417A/zh active Pending
- 2016-01-15 CN CN202311249309.XA patent/CN117100756A/zh active Pending
- 2016-01-15 AU AU2016210540A patent/AU2016210540B2/en active Active
- 2016-01-15 JP JP2017539029A patent/JP6772151B2/ja active Active
- 2016-01-15 EA EA201791319A patent/EA201791319A1/ru unknown
- 2016-01-15 WO PCT/IN2016/050017 patent/WO2016116950A2/en not_active Ceased
-
2020
- 2020-09-30 JP JP2020166136A patent/JP2021006555A/ja active Pending
-
2024
- 2024-12-02 US US18/965,790 patent/US20250090546A1/en active Pending
-
2025
- 2025-01-23 JP JP2025010109A patent/JP2025066799A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018012722A5 (enExample) | ||
| US20080275120A1 (en) | Leucine rich composition | |
| JP2004359663A (ja) | 尿酸を削減するためのヒスチジンおよびアラニンのジペプチドを含有する組成物およびそのジペプチドを用いる尿酸を削減するための方法 | |
| JP2019517542A5 (enExample) | ||
| CA3073184A1 (en) | A pharmaceutical composition for anaemia | |
| JP2018502893A5 (enExample) | ||
| CN105407907A (zh) | 尿酸值下降剂 | |
| JP7311267B2 (ja) | 急性肝不全及び他の肝毒性状態を治療及び／又はこれらから保護するための方法及び製剤 | |
| RU2010120706A (ru) | Композиция липоевой кислоты в виде шариков | |
| CY1108138T1 (el) | Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι | |
| EP1499342A2 (en) | Therapeutic composition for treatment of cancer by arginine depletion | |
| CN103751767A (zh) | 一种药物组合物及其应用 | |
| WO2016116950A3 (en) | Chlorophyll composition | |
| EA200600176A1 (ru) | Фармацевтические композиции, содержащие аскорбиновую кислоту для лечения грибковых суперинфекций и грибковых рецидивов | |
| JPWO2002043752A1 (ja) | インターフェロン治療効果増強剤 | |
| Baghbanian et al. | Thrombotic microangiopathy associated with interferon-beta treatment in patients with multiple sclerosis | |
| CN115427417A (zh) | 含有三磷酸腺苷（atp）的组合物和使用方法 | |
| CN110891574B (zh) | 用于预防和/或治疗肝细胞癌的美格列明 | |
| JP3249547U (ja) | マーレーコッドから抽出ペプチドの粒子構造 | |
| JP2018510213A5 (enExample) | ||
| CN112055583A (zh) | 用于止痛和助眠的富含钾的局部制剂 | |
| CN108042634A (zh) | 一种具有解酒护肝作用的组合物及其制备方法 | |
| JP2019529554A5 (enExample) | ||
| TW200940075A (en) | Agent for alleviating adverse side effects produced in interferon/ribavirin combination therapy | |
| JP2010174007A (ja) | レッドペッパー・ガーリック（カプセル）。 |